vs
CorMedix Inc.（CRMD）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
CorMedix Inc.的季度营收约是Resolute Holdings Management, Inc.的1.1倍（$128.6M vs $117.7M），Resolute Holdings Management, Inc.自由现金流更多（$189.2M vs $92.7M）
CorMedix Inc.是一家处于商业阶段的生物制药企业，专注于开发及商业化用于预防和治疗感染性、炎症性及心肾疾病的创新治疗产品，核心管线针对导管相关血流感染，主要服务北美、欧洲的重症监护及长期透析患者群体。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
CRMD vs RHLD — 直观对比
营收规模更大
CRMD
是对方的1.1倍
$117.7M
自由现金流更多
RHLD
多$96.5M
$92.7M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $128.6M | $117.7M |
| 净利润 | — | $-1.7M |
| 毛利率 | 83.4% | 55.7% |
| 营业利润率 | 46.0% | 30.2% |
| 净利率 | — | -1.5% |
| 营收同比 | — | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.20 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRMDRHLD
| Q4 25 | $128.6M | $117.7M | ||
| Q3 25 | $104.3M | $120.9M | ||
| Q2 25 | $39.7M | $119.6M | ||
| Q1 25 | $39.1M | $103.9M |
净利润CRMDRHLD
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $108.6M | $-231.0K | ||
| Q2 25 | $19.8M | $-611.0K | ||
| Q1 25 | $20.6M | $-3.4M |
毛利率CRMDRHLD
| Q4 25 | 83.4% | 55.7% | ||
| Q3 25 | 89.3% | 59.0% | ||
| Q2 25 | 95.3% | 57.5% | ||
| Q1 25 | 95.9% | 52.5% |
营业利润率CRMDRHLD
| Q4 25 | 46.0% | 30.2% | ||
| Q3 25 | 49.2% | 34.3% | ||
| Q2 25 | 49.2% | 34.0% | ||
| Q1 25 | 51.5% | 24.7% |
净利率CRMDRHLD
| Q4 25 | — | -1.5% | ||
| Q3 25 | 104.1% | -0.2% | ||
| Q2 25 | 49.9% | -0.5% | ||
| Q1 25 | 52.8% | -3.2% |
每股收益（稀释后）CRMDRHLD
| Q4 25 | $0.20 | $-0.20 | ||
| Q3 25 | $1.26 | $-0.03 | ||
| Q2 25 | $0.28 | $-0.07 | ||
| Q1 25 | $0.30 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $148.5M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $405.3M | $6.5M |
| 总资产 | $826.1M | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资CRMDRHLD
| Q4 25 | $148.5M | $205.5M | ||
| Q3 25 | $55.7M | $148.0M | ||
| Q2 25 | $190.7M | $99.9M | ||
| Q1 25 | $77.5M | $71.0M |
总债务CRMDRHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M |
股东权益CRMDRHLD
| Q4 25 | $405.3M | $6.5M | ||
| Q3 25 | $374.1M | $10.8M | ||
| Q2 25 | $220.6M | $9.6M | ||
| Q1 25 | $114.9M | $8.9M |
总资产CRMDRHLD
| Q4 25 | $826.1M | $333.4M | ||
| Q3 25 | $750.9M | $293.2M | ||
| Q2 25 | $252.6M | $253.3M | ||
| Q1 25 | $149.6M | $214.3M |
负债/权益比CRMDRHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $94.5M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $92.7M | $189.2M |
| 自由现金流率自由现金流/营收 | 72.1% | 160.8% |
| 资本支出强度资本支出/营收 | 1.3% | 5.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $172.8M | $313.2M |
8季度趋势，按日历期对齐
经营现金流CRMDRHLD
| Q4 25 | $94.5M | $196.1M | ||
| Q3 25 | $30.9M | $59.6M | ||
| Q2 25 | $30.0M | $48.9M | ||
| Q1 25 | $19.7M | $18.4M |
自由现金流CRMDRHLD
| Q4 25 | $92.7M | $189.2M | ||
| Q3 25 | $30.4M | $58.6M | ||
| Q2 25 | $30.0M | $47.5M | ||
| Q1 25 | $19.7M | $17.8M |
自由现金流率CRMDRHLD
| Q4 25 | 72.1% | 160.8% | ||
| Q3 25 | 29.1% | 48.5% | ||
| Q2 25 | 75.4% | 39.7% | ||
| Q1 25 | 50.5% | 17.1% |
资本支出强度CRMDRHLD
| Q4 25 | 1.3% | 5.8% | ||
| Q3 25 | 0.5% | 0.8% | ||
| Q2 25 | 0.1% | 1.2% | ||
| Q1 25 | 0.0% | 0.6% |
现金转化率CRMDRHLD
| Q4 25 | — | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 0.96× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRMD
| Acquisition Of Melinta | $52.9M | 41% |
| Melinta Portfolio | $45.5M | 35% |
| Other | $18.6M | 14% |
| Contract Revenue | $7.4M | 6% |
| BARDA Agreement | $4.2M | 3% |
RHLD
暂无分部数据
